Riitta Tuompo

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin et al. · BMJ · 2020 · 108 citations · Full text

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin et al. · Annals of the Rheumatic Diseases · 2023 · 44 citations · Full text

Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study

Kalle Aaltonen, Liisa Virkki, Esa Jämsen et al. · Seminars in Arthritis and Rheumatism · 2013 · 43 citations

Rheumatoid Disorder, Rheumatology, Biologic Drugs +8

Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis

Riitta Tuompo, Timo Hannu, Elisa Huovinen et al. · Rheumatology International · 2017 · 34 citations · Full text

Rheumatoid Disorder, Rheumatology, Reactive Arthritis +12

Reactive arthritis following<i>Salmonella</i>infection: a population-based study

Riitta Tuompo, Timo Hannu, L Mattila et al. · Scandinavian Journal of Rheumatology · 2013 · 27 citations